Raltegravir, sold under the brand name Isentress, is an antiretroviral medication used, together with other medication, to treat HIV/AIDS. It may also...
17 KB (1,459 words) - 21:09, 4 September 2024
for raltegravir (brand name Isentress). Research published at the time supported the conclusion that "[for people living with HIV,] raltegravir plus...
6 KB (622 words) - 17:42, 23 December 2023
Lamivudine/raltegravir, sold under the brand name Dutrebis, is a fixed-dose combination antiretroviral medication used in the treatment of HIV/AIDS. It...
3 KB (136 words) - 19:50, 20 December 2023
of tenofovir disoproxil to be taken once daily, and 400 mg pills of raltegravir to be taken twice daily. People initiating nPEP treatment typically receive...
31 KB (3,370 words) - 15:50, 1 September 2024
Indinavir Lamivudine (3TC) Lopinavir Maraviroc Nelfinavir Nevirapine Raltegravir Ritonavir Saquinavir Tenofovir Tipranavir Zalcitabine (ddC) Zidovudine...
26 KB (1,685 words) - 02:08, 21 February 2024
all known and appear in a variety of pharmaceutical drugs including raltegravir, butalamine, fasiplon, oxolamine, and pleconaril. The 1,2,3-isomer is...
2 KB (152 words) - 20:09, 22 July 2019
Darunavir Lopinavir/ritonavir (lopinavir + ritonavir) Ritonavir Dolutegravir Raltegravir Abacavir/lamivudine (abacavir + lamivudine) Dolutegravir/lamivudine/tenofovir...
67 KB (4,835 words) - 05:59, 17 August 2024
under clinical trial,[when?] and raltegravir became the first to receive FDA approval in October 2007. Raltegravir has two metal binding groups that...
133 KB (16,990 words) - 13:40, 24 August 2024
2020 revenue. Other major products by the company include Isentress (raltegravir), an antiretroviral medication used to treat HIV/AIDS that had $857 million...
96 KB (9,413 words) - 14:30, 14 September 2024
3.54% Johnson & Johnson HIV infection Jun-2006 Mon-20XX 61 Isentress Raltegravir 248,924 0.72% Merck & Co., Inc. HIV Infection Dec-1998 Mon-20XX 62 Janumet...
29 KB (281 words) - 06:29, 12 August 2024